Bret A. Lashner

Infliximab Maintenance Therapy for Fistulizing Crohn's Disease

Bruce E. Sands, Frank Anderson, Çharles N. Bernstein et al. · New England Journal of Medicine · 2004 · 2.2K citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +13

Natalizumab for the Treatment of Active Crohn’s Disease: Results of the ENCORE Trial

Stephan R. Targan, Brian G. Feagan, Richard N. Fedorak et al. · Gastroenterology · 2007 · 614 citations

Medicine, Internal Medicine, Pharmacotherapy +8

Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease

Paul Rutgeerts, Robert H. Diamond, Mohan Bala et al. · Gastrointestinal Endoscopy · 2006 · 549 citations

Pharmacy, Pharmacotherapy, Gastrointestinal Pharmacotherapy +13

Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease

Stefan Schreiber, Richard N. Fedorak, Ole Haagen Nielsen et al. · Gastroenterology · 2000 · 460 citations · Full text

Veterinary Medicine, Immunology, Clinical Immunology +13

A Randomized Clinical Trial of Ciprofloxacin and Metronidazole to Treat Acute Pouchitis

Bo Shen, Jean-Paul Achkar, Bret A. Lashner et al. · Inflammatory Bowel Diseases · 2001 · 350 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10